Control of Acute Cisplatin-lnduced Emesis over Repeat Courses of Chemotherapy

Oncology (Switzerland)

Volumn 53, Issue 1, 1996, Pages 65-72

  Roila, F ^a  

^a Ospedale Policlinico   (Italy)

Author keywords

Cisplatin; Dexamethasone; Emesis; Metoclopramide; Nausea; Ondansetron; Prognostic factors

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; METHYLPREDNISOLONE; METOCLOPRAMIDE; ONDANSETRON; SEROTONIN 3 ANTAGONIST;

ANTIEMETIC ACTIVITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; HIGH RISK PATIENT; HOT FLUSH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; SWEATING; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; SEROTONIN ANTAGONISTS; VOMITING;

EID: 0029839763     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227643     Document Type: Article

References (23)

1. Coates A, Abraham S, Kaye SB, Sowcrbutts T, Frewin C, Fox RM, Tattersall HN: On the receiving end - Patient perception of the side-effects of cancer chemotherapy, Eur J Cancer Clin Oncol 1983:19:203-208.
2. Morrow GR: Chemotherapy-related nausea and vomiting: Etiology and management, CA Cancer J Clin 1989:39:89-104.
3. Laszlo J: Nausea and vomiting as major complications of cancer chcmothcrapv, Drugs 1983:25(suppl 1): 1-7.
4. Roila F, Tonato M, Basurto C, Bella R, Passal-acqua R, Morsia D, DiCostanzo F, Donati D, Ballatori E, Tognoni G, Franzosi MG, Del Fa-vcro A: Antiemctic activity of high doses of metoclopramidc combined with methylprcd-nisolone versus mctoclopramide alone in cis-platin-treated cancer patients: A randomized double-blind trial of the Italian Oncology Group for Clinical Research, J Clin Oncol 1987:5:141-149.
5. Kris MG, Gralla RJ, Tyson LB, Clark RA, Kelsen DP, Reilly LK, Groshen S, Bosl GJ, Kalman LA: Improved control of cisplatin-induccd emesis with high-dose metoclopramide and with combinations of mctoclopramide, dexamethasone, and diphenhydramine, Results of consecutive trials in 255 patients, Cancer 1985:55:527-534.
6. Grunberg SM, Akcrlcv WL, Krailo MD: Comparison of metoclopramide and metoclopramidc plus dexamethasone for complete protection from cisplatin-induced emesis, Canccr Invest 1986:4:379-385.
7. Allan SG, Cornbleet MA, Warrington PS, Gol-land IM, Leonard RC, Smyth JN: Dexamctha-sone and high-dose mctoclopramidc: Efficacy in controlling cisplatin-induced nausea and vomiting, Br Med J 1984:289:878-879.
8. Benrubi GL, Norvell M, Nuss RC, Robinson H: The use of methylprednisolone and mctoclopramidc in control of emesis in patients receiving cis-platinum, Gynecol Oncol 1985:21:306-313.
9. Roila F, Tonato M, Basurto C, Picciafuoco M, Bracarda S, Donati D, Malacarnc P, Monici L, Di Costanzo F, Patoia L, Ballatori E: Protection from nausea and vomiting in cisplatin-treated patients: Fligh-dose mctoclopramide combined with methylprednisolone versus metoclopramidc combined with dexamethasone and diphenhydramine: A study of the Italian Oncology Group for Clinical Research, J Clin Oncol 1989;7:1693-1700.
10. Kris MG, Gralla RJ, Clark RA, Tyson LB, Groshen S: Antiemetic control and prevention of sidc-cffccts of anti-canccr therapy with lora-zcpam or diphenhydramine when used in combination with mctoclopramide plus dexamethasone, Cancer 1987:60:2816-2822.
11. De Mulder PHM, Scynaeve C, Vermorkcn JB, van Licssum PA, Mols-Jcvdevic S, Lane All-man E, Bcrancck P, Verweij J: Ondansetron compared with high-dose metoclopramidc in the prophylaxis of acutc and delayed cisplatin-induccd nausea and vomiting - A multiccntre randomised, double-blind crossover study, Ann Intern Med 1990:113:834-840.
12. Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N, Pujade-Laurainc E, Paule B, Paes D, Bons J: Comparison of the 5-hydroxytrypta-mine-3 (serotonin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis, N Engl J Med 1990:322:816-821.
13. Hainsworth J, Harvey W, Pendergrass K, Ka-simis B, Obion D, Monaghan G, Gandara D, Hesketh P, Khojastch A, Harker G, York M, Siddiqui T, Finn A: A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous mctoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy, J Clin Oncol 1991:9:721-728.
14. Roila F, Tonato M, Cognetti F, Cortesi E, Favalli G, Marangolo M, Amadori D, Bella MA, Gramazio V, Donati D: Prevention of cisplatin-induccd emesis: A double-blind multicentre randomised crossover study comparing ondansetron and ondansetron plus dexamethasone, J Clin Oncol 1991:9:675-678.
15. Smyth JE, Coleman RE, Nicolson M, Gall-meier WM, Leonard RCF, Cornbleet MA, Allan SG, Upadhyaya BK, Bruntsch U: Does dexamethasone enhance control of acute cisplatin-induccd emesis by ondansetron? Br J Med 1991:303:1423-1426.
16. Italian Group for Anticmetic Research: Ondansetron + dexamethasone vs, mctoclopramidc + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis, Lancet 1992;340:96-99.
17. Italian Group for Antiemetic Research: Difference in persistence of efficacy of two anti-emct-ic regimens on acute emesis during cisplatin chemotherapy, J Clin Oncol 1993:11:2396-2404.
18. Kris MG, Gralla RJ, Clark RA, Tyson LB, O'Connell JP, Wertheim MS, Kelsen DP: Incidence, course and severity of delayed nausea and vomiting following administration of high-dose cisplatin, J Clin Oncol 1985:3:1379- 1382.
19. Roila F, Boschctti E, Tonato M, Basurto C, Bracarda S, Picciafuoco M, Patoia L, Santi E, Penza O, Ballatori E: Predictive factors of delayed emesis in cisplatin-treated patients and antiemctic activity and tolerability of mctoclopramide or dexamethasone, A randomized single blind study, Am J Clin Oncol 1991; 14:238-243.
20. Kris MG, Gralla RJ, Tyson LB, Clark RA, Cir-rincione C, Groshen S: Controlling delayed vomiting: Double-blind randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin, J Clin Oncol 1989:7:108-114.
21. Kris MG, Tyson LB, Clark RA, Gralla RJ: Oral ondansetron for the control of delayed emesis after cisplatin, Cancer 1992;70(suppl): 1012- 1016.
22. Gandara DR: Progress in the control of acute and delayed emesis induced by cisplatin, Eur J Cancer 1991:27(suppl 1):9-11.
23. Italian Group for Antiemctic Research: Cisplatin-induced delayed emesis: Pattern and prognostic factors during three subsequent cycles, Ann Oncol 1994:5:585-589.